A Leading Israeli Cannabis Producer Is Set to Expand With Canadian… – New Cannabis Ventures

Exclusive Interview with IM Cannabis Co-Founder and CEO Oren Shuster

IM Cannabis (CSE: IMCC) (OTC: IMCNF) is set to add Canada to its global footprint with the pending acquisition of Trichome Financial (CSE: TFC) (OTC: TRICF). IMC Co-Founder and CEO Oren Shuster spoke with New Cannabis Ventures about the company’s established operations in Israel and Germany and how the Trichome acquisition will help to drive the company forward. The audio of the entire conversation is available at the end of this written summary.

Global Team

Shuster’s background is in healthcare technology and software. He started a business with a partner more than 20 years ago. He was first approached with the idea of medical cannabis in 2010, and he decided to pursue the opportunity.

The IM Cannabis team’s strength, across all of its major markets, is key to its success, according to Shuster.  Marc Lustig, who successfully exited Origin House when Cresco Labs acquired it in 2020, brings years of experience in financial markets and strategy to his role as Executive Chairman. Richard Balla, CEO of IMC’s German operations, is another vital member of the team. With the acquisition of Trichome, Michael Ruscetta and Howard Steinberg will be joining IMC’s group of experienced global leaders.


Previous post Medical cannabinoid firm GW Pharma to be acquired by Jazz Pharmaceuticals for $7.2 billion – Marijuana Business Daily
Next post New Mexico cannabis rules not backed by evidence, judge says – KOB